ATE269861T1 - Substituierte indolalkansäure - Google Patents
Substituierte indolalkansäureInfo
- Publication number
- ATE269861T1 ATE269861T1 AT99916239T AT99916239T ATE269861T1 AT E269861 T1 ATE269861 T1 AT E269861T1 AT 99916239 T AT99916239 T AT 99916239T AT 99916239 T AT99916239 T AT 99916239T AT E269861 T1 ATE269861 T1 AT E269861T1
- Authority
- AT
- Austria
- Prior art keywords
- indolalkanic
- substituted
- acid
- substituted indolalkanic
- indolalkanic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8014398P | 1998-03-31 | 1998-03-31 | |
PCT/US1999/007116 WO1999050268A2 (en) | 1998-03-31 | 1999-03-31 | Substituted indolealkanoic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE269861T1 true ATE269861T1 (de) | 2004-07-15 |
Family
ID=22155536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99916239T ATE269861T1 (de) | 1998-03-31 | 1999-03-31 | Substituierte indolalkansäure |
Country Status (29)
Country | Link |
---|---|
US (9) | US6214991B1 (de) |
EP (1) | EP1066283B1 (de) |
JP (2) | JP3494990B2 (de) |
KR (1) | KR100584650B1 (de) |
CN (1) | CN1205207C (de) |
AP (1) | AP2000001929A0 (de) |
AT (1) | ATE269861T1 (de) |
AU (1) | AU774929B2 (de) |
BG (1) | BG65446B1 (de) |
BR (1) | BR9909358A (de) |
CA (1) | CA2383983C (de) |
CZ (1) | CZ300706B6 (de) |
DE (1) | DE69918278T2 (de) |
EE (1) | EE200000573A (de) |
ES (1) | ES2224632T3 (de) |
HU (1) | HUP0101672A3 (de) |
ID (1) | ID27884A (de) |
IL (2) | IL138711A0 (de) |
MX (1) | MXPA02003122A (de) |
NO (1) | NO20004900L (de) |
NZ (1) | NZ507172A (de) |
OA (1) | OA11622A (de) |
PL (1) | PL201645B1 (de) |
SK (1) | SK7522001A3 (de) |
TR (1) | TR200002869T2 (de) |
TW (1) | TWI243163B (de) |
WO (1) | WO1999050268A2 (de) |
YU (1) | YU59600A (de) |
ZA (1) | ZA200005577B (de) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3494990B2 (ja) * | 1998-03-31 | 2004-02-09 | ザ インスティテューツ フォア ファーマスーティカル ディスカヴァリー エルエルシー | 置換されたインドールアルカノール酸 |
TNSN99224A1 (fr) * | 1998-12-01 | 2005-11-10 | Inst For Pharm Discovery Inc | Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique |
AU5960300A (en) * | 1999-07-15 | 2001-02-05 | Nps Allelix Corp. | Heterocyclic compounds for the treatment of migraine |
US6521659B2 (en) * | 2000-03-02 | 2003-02-18 | Institute For Pharmaceutical Discovery, Llc | Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor |
AU2001259668A1 (en) * | 2000-05-09 | 2001-11-20 | The Institute For Pharmaceutical Discovery Llc | Methods for testing compounds useful for treating diabetic complications |
JP2004517851A (ja) | 2000-12-27 | 2004-06-17 | バイエル アクチェンゲゼルシャフト | 甲状腺受容体のリガンドとしてのインドール誘導体 |
PT1397130E (pt) | 2001-06-20 | 2007-11-13 | Wyeth Corp | Derivados ácidos de indole substituído como inibidores de inibidor 1 do activador de plasminogénio (pai-1) |
TWI224101B (en) | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
EP1465629B1 (de) | 2002-01-18 | 2007-03-14 | Aryx Therapeutics | 5-ht3-rezeptorantagonisten und verwendungsverfahren |
CA2395871A1 (en) * | 2002-07-26 | 2004-01-26 | The Institutes For Pharmaceutical Discovery, Llc | Substituted indolealkanoic acids derivatives and formulations containing same for use in treatment of diabetic complications |
AU2003256926A1 (en) * | 2002-07-26 | 2004-02-16 | The Institutes For Pharmaceutical Discovery, Llc | Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications |
WO2004020408A1 (en) * | 2002-08-29 | 2004-03-11 | Merck & Co., Inc. | Indoles having anti-diabetic activity |
CN1723197A (zh) | 2002-12-10 | 2006-01-18 | 惠氏公司 | 作为纤溶酶原激活物抑制剂-1(pai-1)的抑制剂的取代3-烷基和3-芳基烷基1h-吲哚-1-基乙酸衍生物 |
CN1726191A (zh) | 2002-12-10 | 2006-01-25 | 惠氏公司 | 用作纤溶酶原激活物抑制剂-1(pai-1)的抑制剂的取代的吲哚氧代-乙酰氨基乙酸衍生物 |
ATE331709T1 (de) | 2002-12-10 | 2006-07-15 | Wyeth Corp | Substituierte 3-carbonyl-1-yl essigsäure derivate als plasminogen aktivator inhibitor(pai-1) inhibitoren |
BR0316585A (pt) | 2002-12-10 | 2005-10-04 | Wyeth Corp | Derivados de ácido glioxìlico aril, ariloxi e alquiloxi 1h-indol-3-il substituìdos como inibidores do inibidor-1 do ativador do plasminogênio (pai-1) |
UA80453C2 (en) | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
EP1620088A4 (de) | 2003-04-28 | 2007-08-29 | Bayer Pharmaceuticals Corp | Indolessigsäure-derivate und ihre verwendung als pharmazeutische mittel |
CN1812977A (zh) * | 2003-04-30 | 2006-08-02 | 药物研发有限责任公司 | 取代羧酸 |
ZA200600424B (en) * | 2003-08-01 | 2007-05-30 | Genelabs Tech Inc | Bicyclic imidazol derivatives against flaviviridae |
US7163954B2 (en) | 2003-09-25 | 2007-01-16 | Wyeth | Substituted naphthyl benzothiophene acids |
US7141592B2 (en) | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
US7582773B2 (en) | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
US7332521B2 (en) | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
US7411083B2 (en) | 2003-09-25 | 2008-08-12 | Wyeth | Substituted acetic acid derivatives |
US7446201B2 (en) | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
US7268159B2 (en) | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
US7265148B2 (en) | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
US7351726B2 (en) | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
US7442805B2 (en) | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
GB0324763D0 (en) | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
AU2005302475A1 (en) * | 2004-10-28 | 2006-05-11 | The Institutes For Pharmaceutical Discovery, Llc | Substituted phenylalkanoic acids |
RU2007130896A (ru) * | 2005-01-14 | 2009-02-20 | Дженелэбс Текнолоджиз, Инк. (Us) | Индольные производные для лечения вирусных инфекций |
GB0505048D0 (en) * | 2005-03-11 | 2005-04-20 | Oxagen Ltd | Compounds with PGD antagonist activity |
US20080051384A1 (en) * | 2006-07-14 | 2008-02-28 | Genelabs Technologies, Inc. | Antiviral agents |
NZ574375A (en) | 2006-07-22 | 2011-06-30 | Oxagen Ltd | 2-(5-fluoro-2-methyI-3-(2-(phenylsulfonyl)benzyl)-1H-indol-1-yl) acetic acid derivatives having CRTH2 antagonist activity |
US7750027B2 (en) * | 2008-01-18 | 2010-07-06 | Oxagen Limited | Compounds having CRTH2 antagonist activity |
SI2250161T1 (sl) | 2008-01-18 | 2014-04-30 | Atopix Therapeutics Limited | Spojine, ki imajo aktivnost crth2 antagonista |
JP2011509991A (ja) * | 2008-01-22 | 2011-03-31 | オキサジェン リミテッド | Crth2アンタゴニスト活性を有する化合物 |
EP2265581A1 (de) * | 2008-01-22 | 2010-12-29 | Oxagen Limited | Verbindungen mit crth2-antagonistischer wirkung |
GB2457040A (en) * | 2008-01-30 | 2009-08-05 | Oxagen Ltd | 1-Acetic acid indole derivatives with PGD2 activity |
CN104042617A (zh) | 2009-04-29 | 2014-09-17 | 阿马里纳药物爱尔兰有限公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
US8916563B2 (en) | 2010-07-16 | 2014-12-23 | The Trustees Of Columbia University In The City Of New York | Aldose reductase inhibitors and uses thereof |
CA2804640C (en) * | 2010-07-16 | 2018-09-25 | The Trustees Of Columbia University In The City Of New York | Aldose reductase inhibitors and uses thereof |
GB201322273D0 (en) | 2013-12-17 | 2014-01-29 | Atopix Therapeutics Ltd | Process |
GB201407820D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
GB201407807D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
DK3352754T3 (da) | 2016-06-21 | 2020-12-07 | Univ Columbia | Aldosereduktaseinhibitorer og fremgangsmåder til anvendelse deraf |
CA3071114A1 (en) | 2017-07-28 | 2019-01-31 | Applied Therapeutics Inc. | Compositions and methods for treating galactosemia |
US11530186B2 (en) | 2018-03-29 | 2022-12-20 | H. Lee Moffitt Cancer Center and Research Center Institute, Inc. | Inhibitors for the β-catenin / T-cell factor protein-protein interaction |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3557142A (en) * | 1968-02-20 | 1971-01-19 | Sterling Drug Inc | 4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters |
IE47592B1 (en) | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
DK151884C (da) * | 1979-03-07 | 1988-06-13 | Pfizer | Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf |
JPS55167282A (en) | 1979-06-12 | 1980-12-26 | Fujisawa Pharmaceut Co Ltd | Piperazine derivative or its salt and its preparation |
US4283539A (en) | 1979-12-18 | 1981-08-11 | Pfizer Inc. | Isoquinoline acetic acids |
US4363912A (en) * | 1980-12-15 | 1982-12-14 | Pfizer Inc. | Indole thromboxane synthetase inhibitors |
US4442118A (en) | 1981-07-23 | 1984-04-10 | Ayerst, Mckenna & Harrison, Inc. | Aldose reductase inhibition by 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid |
GB8607294D0 (en) | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
DE3684410D1 (de) * | 1985-11-07 | 1992-04-23 | Pfizer | Heterocyclische oxophthalazinylessigsaeure. |
US4939140A (en) | 1985-11-07 | 1990-07-03 | Pfizer Inc. | Heterocyclic oxophthalazinyl acetic acids |
WO1993012786A1 (en) * | 1986-07-10 | 1993-07-08 | Howard Harry R Jr | Indolinone derivatives |
US4960785A (en) | 1988-12-16 | 1990-10-02 | Pfizer Inc. | Indolinone derivatives |
US4868301A (en) * | 1987-06-09 | 1989-09-19 | Pfizer Inc. | Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains |
US5064852A (en) * | 1988-12-16 | 1991-11-12 | Pfizer Inc. | Indolinone derivatives |
AU5279390A (en) | 1989-03-31 | 1990-11-05 | Kyoto Pharmaceutical Industries, Ltd. | New imidazole derivatives, production thereof, and uses thereof as medicines |
US4996204A (en) * | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
FR2647676A1 (fr) * | 1989-06-05 | 1990-12-07 | Union Pharma Scient Appl | Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase |
GB8916774D0 (en) * | 1989-07-21 | 1989-09-06 | Bayer Ag | New indole derivatives,a process for their preparation and their use in medicaments |
US5304557A (en) | 1989-12-15 | 1994-04-19 | Pfizer Inc. | Substituted oxoophthalazinyl acetic acids and analogs thereof |
US5312829A (en) * | 1990-05-21 | 1994-05-17 | Fujisawa Pharmaceutical Co., Ltd. | Indole derivatives |
GB9011335D0 (en) | 1990-05-21 | 1990-07-11 | Fujisawa Pharmaceutical Co | Indolebutyric acid derivatives and process for preparation thereof |
US5236945A (en) * | 1990-06-11 | 1993-08-17 | Pfizer Inc. | 1H-indazole-3-acetic acids as aldose reductase inhibitors |
US5116753A (en) | 1991-07-30 | 1992-05-26 | The Salk Institute For Biological Studies | Maintenance of pancreatic islets |
JPH0641071A (ja) * | 1991-09-06 | 1994-02-15 | Taisho Pharmaceut Co Ltd | インドール酢酸エステル誘導体 |
GB9122590D0 (en) | 1991-10-24 | 1991-12-04 | Lilly Industries Ltd | Pharmaceutical compounds |
US5391551A (en) | 1993-05-10 | 1995-02-21 | Pfizer Inc. | Method of lowering blood lipid levels |
GB9317764D0 (en) * | 1993-08-26 | 1993-10-13 | Pfizer Ltd | Therapeutic compound |
GB9409583D0 (en) | 1994-05-13 | 1994-07-06 | Pfizer Ltd | Indoles |
US5641800A (en) * | 1994-07-21 | 1997-06-24 | Eli Lilly And Company | 1H-indole-1-functional sPLA2 inhibitors |
TW401301B (en) | 1994-10-07 | 2000-08-11 | Takeda Chemical Industries Ltd | Antihypertriglyceridemic composition |
US5700819A (en) * | 1994-11-29 | 1997-12-23 | Grelan Pharmaceutical Co., Ltd. | 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications |
IL117208A0 (en) * | 1995-02-23 | 1996-06-18 | Nissan Chemical Ind Ltd | Indole type thiazolidines |
KR19980703048A (ko) * | 1995-03-20 | 1998-09-05 | 피터쥐.스트링거 | 5-치환-3-(1,2,3,6-테트라히드로피리딘-4-일)- 및 3-(피페리딘-4-일)-1h-인돌: 신규한 5-ht1f 아고니스트 |
JPH09165371A (ja) | 1995-10-09 | 1997-06-24 | Sankyo Co Ltd | 複素環化合物を含有する医薬 |
DE19636150A1 (de) * | 1996-09-06 | 1998-03-12 | Asta Medica Ag | N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung |
JP3494990B2 (ja) * | 1998-03-31 | 2004-02-09 | ザ インスティテューツ フォア ファーマスーティカル ディスカヴァリー エルエルシー | 置換されたインドールアルカノール酸 |
TNSN99224A1 (fr) | 1998-12-01 | 2005-11-10 | Inst For Pharm Discovery Inc | Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique |
US6521659B2 (en) * | 2000-03-02 | 2003-02-18 | Institute For Pharmaceutical Discovery, Llc | Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor |
-
1999
- 1999-03-31 JP JP2000541171A patent/JP3494990B2/ja not_active Expired - Fee Related
- 1999-03-31 YU YU59600A patent/YU59600A/sh unknown
- 1999-03-31 DE DE69918278T patent/DE69918278T2/de not_active Expired - Lifetime
- 1999-03-31 AP APAP/P/2000/001929A patent/AP2000001929A0/en unknown
- 1999-03-31 AU AU34595/99A patent/AU774929B2/en not_active Ceased
- 1999-03-31 BR BR9909358-8A patent/BR9909358A/pt not_active Application Discontinuation
- 1999-03-31 IL IL13871199A patent/IL138711A0/xx active IP Right Grant
- 1999-03-31 SK SK752-2001A patent/SK7522001A3/sk not_active Application Discontinuation
- 1999-03-31 CZ CZ20003607A patent/CZ300706B6/cs not_active IP Right Cessation
- 1999-03-31 MX MXPA02003122A patent/MXPA02003122A/es active IP Right Grant
- 1999-03-31 ES ES99916239T patent/ES2224632T3/es not_active Expired - Lifetime
- 1999-03-31 KR KR1020007010884A patent/KR100584650B1/ko not_active IP Right Cessation
- 1999-03-31 WO PCT/US1999/007116 patent/WO1999050268A2/en active IP Right Grant
- 1999-03-31 TR TR2000/02869T patent/TR200002869T2/xx unknown
- 1999-03-31 US US09/282,280 patent/US6214991B1/en not_active Expired - Fee Related
- 1999-03-31 AT AT99916239T patent/ATE269861T1/de not_active IP Right Cessation
- 1999-03-31 EP EP99916239A patent/EP1066283B1/de not_active Expired - Lifetime
- 1999-03-31 CN CNB998047732A patent/CN1205207C/zh not_active Expired - Fee Related
- 1999-03-31 HU HU0101672A patent/HUP0101672A3/hu unknown
- 1999-03-31 OA OA1200000269A patent/OA11622A/en unknown
- 1999-03-31 CA CA002383983A patent/CA2383983C/en not_active Expired - Fee Related
- 1999-03-31 ID IDW20002212A patent/ID27884A/id unknown
- 1999-03-31 EE EEP200000573A patent/EE200000573A/xx unknown
- 1999-06-02 TW TW088109147A patent/TWI243163B/zh not_active IP Right Cessation
-
2000
- 2000-09-26 IL IL138711A patent/IL138711A/en not_active IP Right Cessation
- 2000-09-29 BG BG104819A patent/BG65446B1/bg unknown
- 2000-09-29 NO NO20004900A patent/NO20004900L/no not_active Application Discontinuation
- 2000-10-11 ZA ZA200005577A patent/ZA200005577B/en unknown
-
2001
- 2001-03-27 US US09/818,808 patent/US6426344B2/en not_active Expired - Fee Related
-
2002
- 2002-03-01 PL PL348244A patent/PL201645B1/pl not_active IP Right Cessation
- 2002-03-01 NZ NZ507172A patent/NZ507172A/en unknown
- 2002-06-28 US US10/185,863 patent/US6730794B2/en not_active Expired - Fee Related
- 2002-10-02 JP JP2002290240A patent/JP2003155274A/ja active Pending
-
2004
- 2004-04-27 US US10/832,724 patent/US7105514B2/en not_active Expired - Fee Related
-
2006
- 2006-09-12 US US11/531,151 patent/US7304079B2/en not_active Expired - Fee Related
-
2007
- 2007-12-04 US US11/999,524 patent/US7659269B2/en not_active Expired - Fee Related
-
2010
- 2010-02-08 US US12/701,967 patent/US8163932B2/en not_active Expired - Fee Related
- 2010-08-30 US US12/871,293 patent/US20100324039A1/en not_active Abandoned
-
2012
- 2012-06-27 US US13/534,875 patent/US20120270912A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69918278D1 (de) | Substituierte indolalkansäure | |
ATE239005T1 (de) | (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden | |
DK1100769T3 (da) | Aminomethylcarboxylsyrederivater | |
EE04772B1 (et) | 3-arüül-2-hüdroksüpropaanhappe derivaat (I) | |
ATE248812T1 (de) | Arylsulfonylhydroxamsäurederivate | |
DK1003720T3 (da) | Aryloxyarylsulfonylaminohydroxamsyrederivater | |
NO20006114L (no) | Nytt 3-aryl-2-hydroksypropionsyrederivat III | |
ID23761A (id) | Trisiklik tersubstitusi | |
IS5562A (is) | Nýjar díhýdroxýhexanósýru afleiður | |
ID23219A (id) | Trisiklik tersubstitusi | |
NO991561D0 (no) | 3-alkoksyisoksazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser | |
FI980759A0 (fi) | Taetningskonstruktion foer suglaodan i en sugvals | |
ATE303996T1 (de) | Substituierte acylaminophenyl-uracile | |
DE59912188D1 (de) | Substituierte phenyluracile | |
DE59911610D1 (de) | Substituierte benzoylcyclohexandione | |
FI980619A0 (fi) | Foerfarande foer att minska NOx-foereningar i en sodapannas roekgaser | |
PT1076660E (pt) | (4-bromopirazol-3-il)-benzazolos substituidos | |
EE04061B1 (et) | Metüleenbisfosfoonhappe derivaadid | |
NO980270L (no) | Trekkanordning | |
FI980743A0 (fi) | Gap-valsformare i en pappersmaskin | |
SE9801991D0 (sv) | New 3-aryl-2-hydroxypropionic acid derivative II | |
IDP000021795A (id) | Pirol-pirol tersubstitusi | |
DE29814237U1 (de) | Säureschrank | |
FI980497A0 (fi) | Saett att aendra gassammansaettningen i en gasfasreaktor | |
FI980084A0 (fi) | Foerfarande foer att forhindra vindrutetorkarens fastfrysning i vindrutan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |